Newer versions like Lovenox and Fragmin can be injected under the skin more easily and are safe enough that some patients self-administer the drugs at home.
Given that a large number of corporations are already self-insured and only use health insurance companies to administer their programs, it is not difficult to see how these companies could move to a system where they simply pay the ACO directly rather than use the insurance company as an intermediary.